Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model…

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

patent: 83 patents

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 94 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 83 patents that reference this research output.

Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model…

About this Attention Score

Mentioned by

Citations

Readers on

Lipid nanoparticle compositions and methods for MRNA delivery

Grant US-11951179-B2

United States of America

Lipid nanoparticle compositions and methods for mRNA delivery

Grant US-11951181-B2

United States of America

Lipid nanoparticle compositions and methods for MRNA delivery

Grant US-11951180-B2

United States of America

Varicella zoster virus (VZV) vaccine

Grant US-11918644-B2

United States of America

Immunisation of large mammals with low doses of RNA

Grant US-11913001-B2

United States of America

Immunisation of large mammals with low doses of RNA

Grant US-11905514-B2

United States of America

Immunogenic combination compositions and uses thereof

Grant US-11896636-B2

United States of America

Immunization of large mammals with low doses of RNA

Grant US-11891608-B2

United States of America

Immunisation with lipid formulations with RNA encoding immunogens

Grant US-11883534-B2

United States of America

Methods for purification of messenger RNA

Grant US-11884692-B2

United States of America

Delivery of RNA to trigger multiple immune pathways

Grant US-11865080-B2

United States of America

Lipid formulations with RNA encoding immunogens

Grant US-11857681-B2

United States of America

Delivery of RNA to trigger multiple immune pathways

Grant US-11857562-B2

United States of America

Immunisation of large mammals with low doses of RNA

Grant US-11851660-B2

United States of America

Method of making lipid formulations with RNA encoding immunogens

Grant US-11850305-B2

United States of America

Immunisation of large mammals with low doses of RNA

Grant US-11845925-B2

United States of America

Lipid formulations with viral immunogens

Grant US-11839686-B2

United States of America

Methods for purification of messenger RNA

Grant US-11820977-B2

United States of America

Lipid formulations with immunogens

Grant US-11786467-B2

United States of America

Immunization of large mammals with low doses of RNA

Grant US-11773395-B1

United States of America

Methods of administering lipid formulations with immunogens

Grant US-11766401-B2

United States of America

Pegylated liposomes for delivery of immunogen-encoding RNA

Grant US-11759422-B2

United States of America

Delivery of RNA to trigger multiple immune pathways

Grant US-11759475-B2

United States of America

Immunisation of large mammals with low doses of RNA

Grant US-11739334-B2

United States of America

Delivery of RNA to trigger multiple immune pathways

Grant US-11730754-B2

United States of America